Corrigendum to "Preliminary results of the Global Audit of Treatment of Refractory Status Epilepticus" [Epilepsy Behav. 49C (2015) 318-324], doi:10.1016/j.yebeh.2015.04.010;Preliminary results of the global audit of treatment of refractory status epilepticus

Epilepsy and Behavior

Volumn 49, Issue , 2015, Pages 318-324

  Ferlisi, M ^a   Hocker, S ^b   Grade, M ^d   Trinka, E ^c   Shorvon, S ^d   Singh, Gagandeep ^e   Ercegovac, Marko ^e   O'Brien, Terry ^e   Cook, Mark ^e   Zeid, Yasiri ^e   Kumlien, Eva ^e   Kramer, Uri ^e   Kalviainen, Reetta ^e   Newton, Charles ^e   Nabbout, Rima ^e   Godoy, Daniel ^e   Groppa, Stanislav ^e   Guecht, Alla ^e   Wu, Tony ^e  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b MAYO CLINIC   (United States)

^c PARACELSUS MEDICAL UNIVERSITY   (Austria)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^e NONE

Author keywords

Global audit; Refractory; Registry; Status epilepticus; Super refractory; Treatment

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; ETIRACETAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PROPOFOL; VALPROIC ACID; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; BARBITURIC ACID; INTRAVENOUS ANESTHETIC AGENT; KETAMINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE REGISTRY; DRUG USE; EPILEPTIC STATE; FEMALE; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEWBORN; OUTCOME ASSESSMENT; REFRACTORY STATUS EPILEPTICUS; RISK FACTOR; TIME SERIES ANALYSIS; TIME TO TREATMENT; TREATMENT OUTCOME; COMPLICATION; DRUG RESISTANT EPILEPSY; GENERAL ANESTHESIA; HEALTH CARE SURVEY; MEDICAL AUDIT; MIDDLE AGED; MORTALITY; NERVOUS SYSTEM DISEASES; PRACTICE GUIDELINE; PRESCHOOL CHILD; PROSPECTIVE STUDY; REGISTER; STATUS EPILEPTICUS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANESTHESIA, GENERAL; ANESTHETICS, DISSOCIATIVE; ANESTHETICS, INTRAVENOUS; ANTICONVULSANTS; BARBITURATES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANT EPILEPSY; FEMALE; GUIDELINES AS TOPIC; HEALTH CARE SURVEYS; HUMANS; INFANT; INFANT, NEWBORN; KETAMINE; MALE; MEDICAL AUDIT; MIDAZOLAM; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PROPOFOL; PROSPECTIVE STUDIES; REGISTRIES; STATUS EPILEPTICUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84938991485     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.08.034     Document Type: Erratum

References (33)

1. Shorvon S.D. Status Epilepticus: its Clinical Form and Treatment in Children and Adults 1994, Cambridge University Press, Cambridge.
2. Tiamkao S., Pranbul S., Sawanyawisuth K., Thepsuthammarat K. A national database of incidence and treatment outcomes of status epilepticus in Thailand. Int J Neurosci 2014, 124:416-420. Integrated Epilepsy Research Group.
3. Hesdorffer D.C., Logroscino G., Cascino G., Annegers J.F., Hauser W.A. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 1998, 50:735-741.
4. Dham B.S., Hunter K., Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit Care 2014, 20:476-483.
5. Mayer S.A., Claassen J., Lokin J., Mendelsohn F., Dennis L.J., Fitzsimmons B.F. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002, 59:205-210.
6. Holtkamp M., Othman J., Buchheim K., Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005, 76:534-539.
7. Hocker S., Britton J.W., Mandrekar J., Wijdicks E.F.M., Rabinstein A.A. Predictors of outcome in refractory status epilepticus. JAMA Neurol 2012, 1-6.
8. Kilbride R.D., Reynolds A.S., Szaflarski J.P., Hirsch L.J. Clinical outcomes following prolonged refractory status epilepticus (PRSE). Neurocrit Care 2013, 18(3):374-385.
9. Shorvon S.D. Epidemiology - status epilepticus. Encyclopedia of Basic Epilepsy Research 2009, 1502-1509. Academic Press, Boston. P. Schwartzkroin (Ed.).
10. Treiman D.M., Meyers P.D., Walton N.Y., Collins J.F., Colling C., Rowan A.J., et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998, 339(12):792-798.
11. Alldredge B.K., Gelb A.M., Isaacs S.M., Corry M.D., Allen F., Ulrich S., et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001, 345(9):631-637.
12. Silbergleit R., Durkalski V., Lowenstein D., Conwit R., Pancioli A., Palesch Y., et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012, 366(7):591-600.
13. Bleck T., Cock H., Chamberlain J., Cloyd J., Connor J., Elm J., et al. The established status epilepticus trial 2013. Epilepsia 2013, 54(Suppl. 6):89-92.
14. Ferlisi M., Shorvon S. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 2012, 135(Pt 8):2314-2328.
15. Shorvon S., Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011, 134(Pt 10):2802-2818.
16. Drislane F.W., Blum A.S., Lopez M.R., Gautam S., Schomer D.L. Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia 2009, 50(6):1566-1571.
17. Gaspard N., Foreman B., Judd L.M., Brenton J.N., Nathan B.R., McCoy B.M., et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia 2013, 54(8):1498-1503.
18. Rossetti A.O., Milligan T.A., Vulliémoz S., Michaelides C., Bertschi M., Lee J.W. A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 2011, 14:4-10.
19. Sabers A., Wolf P., Møller A., Rysgaard K., Ben-Menachem E. A prospective, randomized, multicentre trial for the treatment of refractory status epilepticus; experiences from evaluating the effect of the novel drug candidate, NS1209. Epilepsy Res 2013, 106(1-2):292-295.
20. Claassen J., Hirsch L.J., Mayer S.A. Treatment of status epilepticus: a survey of neurologists. J Neurol Sci 2003, 211(1-2):37-41.
21. Rossetti A.O., Alvarez V., Januel J.M., Burnand B. Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol 2013, 260(2):421-428.
22. Ferlisi M., Hocker S. What can we learn from status epilepticus registries?. Epilepsia 2013, 54(Suppl. 6):72-73.
23. Bamford J.M., Sandercock P.A., Warlow C.P., Slattery J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1989, 20:828.
24. Levine M.N., Julian J.A. Registries that show efficacy: good, but not good enough. J Clin Oncol 2008, 26(33):5316-5319.
25. Byar D.P. Why data bases should not replace randomized clinical trials. Biometrics 1980, 36:337-342.
26. Wilder-Smith E.P., Lim E.C., Teoh H.L., Sharma V.K., Tan J.J., Chan B.P., et al. The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity. Ann Acad Med Singapore 2005, 34(7):417-420.
27. Mikaeloff Y., Jambaqué I., Hertz-Pannier L., Zamfirescu A., Adamsbaum C., Plouin P., et al. Devastating epileptic encephalopathy in school-aged children (DESC): a pseudo encephalitis. Epilepsy Res 2006, 69(1):67-79.
28. Nabbout R., Vezzani A., Dulac O., Chiron C. Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol 2011, 10(1):99-108.
29. Macdonald R.L., Kapur J. Acute cellular alterations in the hippocampus after status epilepticus. Epilepsia 1999, 40(Suppl. 1):S9-S20.
30. Vignatelli L., Rinaldi R., Baldin E., Tinuper P., Michelucci R., Galeotti M., et al. Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts. J Neurol 2008, 255(2):197-204.
31. Neligan A., Shorvon S.D. Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review. Arch Neurol 2010, 67:931-940.
32. Sutter R., Marsch S., Fuhr P., Kaplan P.W., Ruegg S. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology 2014, 82:656-664.
33. Hocker S.E., Shorvon S. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology 2014, 83:866.